Jefferies Ups Endo Pharmaceuticals Outlook

Analyst Himanshu Rastogi sees a higher sales forecast for the drug maker's Lidoderm

Jefferies raised estimates on Endo Pharmaceuticals (ENDP ).

To continue reading this article you must be a Bloomberg Professional Service Subscriber.